Paradoxical reaction: can it be seen after completion of the anti-tuberculous therapy?
Mert
Ali
A
Ozaras
Resat
R
D000995:Antitubercular Agents / Q000009:adverse effects* / Q000627:therapeutic use; D018450:Disease Progression; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy; D008875:Middle Aged; D009169:Mycobacterium tuberculosis / Q000302:isolation & purification*; D012307:Risk Factors; D012720:Severity of Illness Index; D016896:Treatment Outcome; D014374:Tuberculin Test; D014388:Tuberculosis, Lymph Node / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy*
D000995:Antitubercular Agents